Yongbiao Huang
Overview
Explore the profile of Yongbiao Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
226
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Xiao L, Li Q, Huang Y, Fan Z, Qin W, Liu B, et al.
Front Cell Dev Biol
. 2022 May;
10:835043.
PMID: 35557945
Lung adenocarcinoma (LUAD) accounts for the majority of lung cancers, and the survival of patients with advanced LUAD is poor. The extracellular matrix (ECM) is a fundamental component of the...
22.
Fu M, Huang Y, Peng X, Li X, Luo N, Zhu W, et al.
Front Cell Dev Biol
. 2022 Apr;
10:790920.
PMID: 35399509
Stomach adenocarcinoma (STAD) is one of the most common tumors. Tumor mutation burden (TMB) has been linked to immunotherapy response. We wanted to see if there was any link between...
23.
Chen X, Tu J, Ma L, Huang Y, Yang C, Yuan X
Int J Gen Med
. 2022 Mar;
15:3215-3235.
PMID: 35342303
Background: Clear cell renal cell carcinoma (ccRCC) is the most aggressive subtype of renal cell carcinoma. Ferroptosis is an iron-dependent programmed cell death. Long non-coding RNAs (lncRNAs) emerge as a...
24.
Xiao L, Li Q, Huang Y, Fan Z, Ma L, Liu B, et al.
J Healthc Eng
. 2022 Mar;
2022:7651758.
PMID: 35251577
Background: Lung adenocarcinoma (LUAD) represents the most common histological subtype of lung cancer. Redox plays a significant role in oncogenesis and antitumor immunity. In this study, we aimed to investigate...
25.
Huang Y, Li S, Huang S, Tu J, Chen X, Xiao L, et al.
Front Bioeng Biotechnol
. 2022 Feb;
10:780751.
PMID: 35155389
More than 200 million people have been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and 4 million deaths have been reported worldwide to date. Cathepsin B/cathepsin L (CTSB/L)...
26.
Huang Y, Chen S, Xiao L, Qin W, Li L, Wang Y, et al.
Front Bioeng Biotechnol
. 2022 Feb;
9:744659.
PMID: 35141213
Kidney renal clear cell carcinoma (KIRC) is a common aggressive malignancy of the urinary system. COVID-19, a highly infectious and severe disease caused by SARS-CoV-2, has become a significant challenge...
27.
Su J, Huang Y, Wang Y, Li R, Deng W, Zhang H, et al.
Cancer Cell Int
. 2022 Feb;
22(1):67.
PMID: 35139863
Background: Copine1 (CPNE1), the first discovered CPNE1 family member, participates in the process of carcinogenesis and development of diverse tumors. Our study aimed to investigate the expression and prognostic value...
28.
Nie X, Yu Q, Li L, Yi M, Wu B, Huang Y, et al.
Front Pharmacol
. 2022 Feb;
13:808576.
PMID: 35126163
Radiation-induced liver fibrosis (RILF) is a serious complication of the radiotherapy of liver cancer, which lacks effective prevention and treatment measures. Kinsenoside (KD) is a monomeric glycoside isolated from ,...
29.
Wang Y, Zheng K, Xiong H, Huang Y, Chen X, Zhou Y, et al.
Front Immunol
. 2022 Jan;
12:762989.
PMID: 34975854
Despite recent improvements in treatment modalities, pancreatic cancer remains a highly lethal tumor with mortality rate increasing every year. Poly (ADP-ribose) polymerase (PARP) inhibitors are now used in pancreatic cancer...
30.
Huang Y, Huang S, Ma L, Wang Y, Wang X, Xiao L, et al.
Front Immunol
. 2021 Dec;
12:723293.
PMID: 34899687
Background: Hepatocellular carcinoma (HCC) is an extremely malignant cancer with poor survival. gene encodes for a variant of H2A histone, and it has been found to be dysregulated in various...